Cite Filings / ACRS / 0000846087-23-000065
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13G/A

Amended Statement of Ownership

Aclaris Therapeutics, Inc. · Filed 2023-02-06 · Acc 0000846087-23-000065

Documents 1

  • SC 13G/A Amended Statement of Ownership , SEC13G_Filing.htm

Around this filing

  • 2023-02-13 SC 13G/A Amended Statement of Ownership
  • 2023-02-06 SC 13G/A Amended Statement of Ownership
  • 2023-02-03 4 Director sold 30,000 shares at an average $16.66 ($499,923)
  • 2023-02-03 4 Options or other derivatives
  • 2023-02-03 4 Options or other derivatives
  • 2023-02-03 4 Chief Business Officer acquired 11,250 shares (option exercise)
  • 2023-01-31 SC 13G/A Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading SEC13G_Filing.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…